Oxford BioMedica (GB:OXB) has released an update.
Institut Merieux SA has significantly increased its stake in Oxford Biomedica PLC, now controlling over 10.93% of the company’s voting rights. This noticeable change in ownership occurred on June 19, 2024, when their subsidiary, TSGH SAS, crossed the notifiable threshold through a securities account held by the French bank, Natixis. The move reflects a strategic positioning by Institut Merieux SA, leveraging control over Oxford Biomedica’s voting rights through its equity ownership in TSGHS SAS.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
